Position history for UBS Group AG's holdings in ERNEXA THERAPEUTICS INC
UBS Group AG holds 21,233 shares of ERNA (ERNEXA THERAPEUTICS INC), worth $4,225 as of 2026-Q1. The position was increased (+3438.8% shares).
Current Value
$4,225
Current Shares
21,233
Total Value Change
+$4,225
Total Shares Change
+21,233
Other major holders of ERNA: Corient Private Wealth LLC
Increased |
| 21,233 |
+3438.8% |
| $4,225 |
| 0.0% |
| $0.30 |
16 |
| 2025-Q4 | New | 600 | - | $720 | 0.0% | $1.17 | 17 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $1.17 | 0 |
| 2025-Q2 | Decreased | 548 | -95.6% | $1,008 | 0.0% | $1.85 | 0 |
| 2025-Q1 | Decreased | 12,473 | -26.0% | $2,220 | 0.0% | $2.55 | 0 |
| 2024-Q4 | Decreased | 16,857 | -79.8% | $4,956 | 0.0% | $4.20 | 0 |
| 2024-Q3 | New | 83,620 | - | $87,801 | 0.0% | $17.25 | 33 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $27.45 | 0 |